Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology

Woo Kyoung Jeong; Hyo Jin Kang; Sang Hyun Choi; Mi Suk Park; Mi Hye Yu; Bohyun Kim; Myung Won You; Sanghyeok Lim; Young Seo Cho; Min Woo Lee; Jeong Ah Hwang; Jae Young Lee; Jung Hoon Kim; Ijin Joo; Jae Seok Bae; So Yeon Kim; Yong Eun Chung; Dong Hwan Kim; Jeong Min Lee

doi:10.3348/kjr.2023.0324

Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology

Woo Kyoung Jeong, Hyo Jin Kang, Sang Hyun Choi, Mi Suk Park, Mi Hye Yu, Bohyun Kim, Myung Won You, Sanghyeok Lim, Young Seo Cho, Min Woo Lee, Jeong Ah Hwang, Jae Young Lee, Jung Hoon Kim, Ijin Joo, Jae Seok Bae, So Yeon Kim, Yong Eun Chung, Dong Hwan Kim, Jeong Min Lee

Department of Radiology

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Sonazoid, a second-generation ultrasound contrast agent, was introduced for the diagnosis of hepatic nodules. To clarify the issues with Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma (HCC), the Korean Society of Radiology and Korean Society of Abdominal Radiology collaborated on the guidelines. The guidelines are de novo, evidence-based, and selected using an electronic voting system for consensus. These include imaging protocols, diagnostic criteria for HCC, diagnostic value for lesions that are inconclusive on other imaging results, differentiation from non-HCC malignancies, surveillance of HCC, and treatment response after locoregional and systemic treatment for HCC.

Original language	English
Pages (from-to)	482-497
Number of pages	16
Journal	Korean Journal of Radiology
Volume	24
Issue number	6
DOIs	https://doi.org/10.3348/kjr.2023.0324
State	Published - Jun 2023

Bibliographical note

Publisher Copyright:
© 2023 The Korean Society of Radiology.

Keywords

Guideline
Hepatocellular carcinoma
Perfluorobutane
Sonazoid
Ultrasound, Contrast-enhanced

Access to Document

10.3348/kjr.2023.0324

Cite this

Jeong, W. K., Kang, H. J., Choi, S. H., Park, M. S., Yu, M. H., Kim, B., You, M. W., Lim, S., Cho, Y. S., Lee, M. W., Hwang, J. A., Lee, J. Y., Kim, J. H., Joo, I., Bae, J. S., Kim, S. Y., Chung, Y. E., Kim, D. H., & Lee, J. M. (2023). Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology. Korean Journal of Radiology, 24(6), 482-497. https://doi.org/10.3348/kjr.2023.0324

@article{3dd0adce5c6344bda9123b8e34fa93a0,

title = "Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology",

abstract = "Sonazoid, a second-generation ultrasound contrast agent, was introduced for the diagnosis of hepatic nodules. To clarify the issues with Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma (HCC), the Korean Society of Radiology and Korean Society of Abdominal Radiology collaborated on the guidelines. The guidelines are de novo, evidence-based, and selected using an electronic voting system for consensus. These include imaging protocols, diagnostic criteria for HCC, diagnostic value for lesions that are inconclusive on other imaging results, differentiation from non-HCC malignancies, surveillance of HCC, and treatment response after locoregional and systemic treatment for HCC.",

keywords = "Guideline, Hepatocellular carcinoma, Perfluorobutane, Sonazoid, Ultrasound, Contrast-enhanced",

author = "Jeong, {Woo Kyoung} and Kang, {Hyo Jin} and Choi, {Sang Hyun} and Park, {Mi Suk} and Yu, {Mi Hye} and Bohyun Kim and You, {Myung Won} and Sanghyeok Lim and Cho, {Young Seo} and Lee, {Min Woo} and Hwang, {Jeong Ah} and Lee, {Jae Young} and Kim, {Jung Hoon} and Ijin Joo and Bae, {Jae Seok} and Kim, {So Yeon} and Chung, {Yong Eun} and Kim, {Dong Hwan} and Lee, {Jeong Min}",

note = "Publisher Copyright: {\textcopyright} 2023 The Korean Society of Radiology.",

year = "2023",

month = jun,

doi = "10.3348/kjr.2023.0324",

language = "English",

volume = "24",

pages = "482--497",

journal = "Korean Journal of Radiology",

issn = "1229-6929",

publisher = "Korean Radiological Society",

number = "6",

}

Jeong, WK, Kang, HJ, Choi, SH, Park, MS, Yu, MH, Kim, B, You, MW, Lim, S, Cho, YS, Lee, MW, Hwang, JA, Lee, JY, Kim, JH, Joo, I, Bae, JS, Kim, SY, Chung, YE, Kim, DH & Lee, JM 2023, 'Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology', Korean Journal of Radiology, vol. 24, no. 6, pp. 482-497. https://doi.org/10.3348/kjr.2023.0324

Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology. / Jeong, Woo Kyoung; Kang, Hyo Jin; Choi, Sang Hyun et al.
In: Korean Journal of Radiology, Vol. 24, No. 6, 06.2023, p. 482-497.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography

T2 - 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology

AU - Jeong, Woo Kyoung

AU - Kang, Hyo Jin

AU - Choi, Sang Hyun

AU - Park, Mi Suk

AU - Yu, Mi Hye

AU - Kim, Bohyun

AU - You, Myung Won

AU - Lim, Sanghyeok

AU - Cho, Young Seo

AU - Lee, Min Woo

AU - Hwang, Jeong Ah

AU - Lee, Jae Young

AU - Kim, Jung Hoon

AU - Joo, Ijin

AU - Bae, Jae Seok

AU - Kim, So Yeon

AU - Chung, Yong Eun

AU - Kim, Dong Hwan

AU - Lee, Jeong Min

PY - 2023/6

Y1 - 2023/6

N2 - Sonazoid, a second-generation ultrasound contrast agent, was introduced for the diagnosis of hepatic nodules. To clarify the issues with Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma (HCC), the Korean Society of Radiology and Korean Society of Abdominal Radiology collaborated on the guidelines. The guidelines are de novo, evidence-based, and selected using an electronic voting system for consensus. These include imaging protocols, diagnostic criteria for HCC, diagnostic value for lesions that are inconclusive on other imaging results, differentiation from non-HCC malignancies, surveillance of HCC, and treatment response after locoregional and systemic treatment for HCC.

AB - Sonazoid, a second-generation ultrasound contrast agent, was introduced for the diagnosis of hepatic nodules. To clarify the issues with Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma (HCC), the Korean Society of Radiology and Korean Society of Abdominal Radiology collaborated on the guidelines. The guidelines are de novo, evidence-based, and selected using an electronic voting system for consensus. These include imaging protocols, diagnostic criteria for HCC, diagnostic value for lesions that are inconclusive on other imaging results, differentiation from non-HCC malignancies, surveillance of HCC, and treatment response after locoregional and systemic treatment for HCC.

KW - Guideline

KW - Hepatocellular carcinoma

KW - Perfluorobutane

KW - Sonazoid

KW - Ultrasound, Contrast-enhanced

UR - http://www.scopus.com/inward/record.url?scp=85161320068&partnerID=8YFLogxK

U2 - 10.3348/kjr.2023.0324

DO - 10.3348/kjr.2023.0324

M3 - Article

C2 - 37271203

AN - SCOPUS:85161320068

SN - 1229-6929

VL - 24

SP - 482

EP - 497

JO - Korean Journal of Radiology

JF - Korean Journal of Radiology

IS - 6

ER -

Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this